Literature summary extracted from

Bacolod, M.D.; Johnson, S.P.; Pegg, A.E.; Dolan, M.E.; Moschel, R.C.; Bullock, N.S.; Fang, Q.; Colvin, O.M.; Modrich, P.; Bigner, D.D.; Friedman, H.S.
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations (2004), Mol. Cancer Ther., 3, 1127-1135.

Application

EC Number	Application	Comment	Organism
2.1.1.63	medicine	clonal selection of AGT mutants during trteatment with O6-benzylguanine plus an alkylator may produce resistance to this intervention in clinical settings	Homo sapiens

Protein Variants

EC Number	Protein Variants	Comment	Organism
2.1.1.63	G156C	mutant form expressed by the medulloblastoma cell line D283 MED, mutant enzyme is not easily inhibited by O6-benzylguanine	Homo sapiens
2.1.1.63	K165T	mutant form expressed by the medulloblastoma cell line D341 MED, mutant enzyme is not easily inhibited by O6-benzylguanine	Homo sapiens
2.1.1.63	Y114F	mutant form expressed by the medulloblastoma cell line Daoy, mutant enzyme is not easily inhibited by O6-benzylguanine	Homo sapiens

Organism

EC Number	Organism	UniProt	Comment	Textmining
2.1.1.63	Homo sapiens	-	-	-

Source Tissue

EC Number	Source Tissue	Comment	Organism	Textmining
2.1.1.63	medulloblastoma cell	D283 MED, D341 MED and Daoy	Homo sapiens	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)